Sensorineural Hearing Loss following Imatinib (Gleevec) Administration

被引：14
作者：
Lin, Harrison W. [1 ,2 ]
Roberts, Daniel S. [1 ,2 ]
Kay, Jonathan [3 ]
Stankovic, Konstantina M. [1 ,2 ]
机构：
[1] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA
[3] Univ Massachusetts, Sch Med, Dept Med, Div Rheumatol, Worcester, MA USA
来源：
OTOLARYNGOLOGY-HEAD AND NECK SURGERY | 2012年 / 146卷 / 02期
关键词：
imatinib; hearing loss; ototoxicity; nephrogenic systemic fibrosis;
D O I：
10.1177/0194599811415008
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
[No abstract available]
引用
收藏
页码：335 / 337
页数：3
相关论文
共 5 条
[1]   Irreversible sensorineural hearing loss due to Imatinib [J].
Attili, Venkata Satya Suresh ;
Bapsy, P. P. ;
Anupama, G. ;
Lokanatha, D. .
LEUKEMIA RESEARCH, 2008, 32 (06) :991-992
[2]   Making and breaking the innervation of the ear: neurotrophic support during ear development and its clinical implications [J].
Fritzsch, B ;
Pirvola, U ;
Ylikoski, J .
CELL AND TISSUE RESEARCH, 1999, 295 (03) :369-382
[3]   A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment [J].
Janssen, Jeroen J. W. M. ;
Berendse, Henk W. ;
Schuurhuis, Gerrit-Jan ;
Merle, Pauline A. ;
Ossenkoppele, Gert J. .
AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (10) :679-682
[4]   Imatinib mesylate treatment of nephrogenic systemic fibrosis [J].
Kay, Jonathan ;
High, Whitney A. .
ARTHRITIS AND RHEUMATISM, 2008, 58 (08) :2543-2548
[5]   Genes responsible for human hereditary deafness: Symphony of a thousand [J].
Petit, C .
NATURE GENETICS, 1996, 14 (04) :385-391
1